<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04168047</url>
  </required_header>
  <id_info>
    <org_study_id>2016/381/HP</org_study_id>
    <nct_id>NCT04168047</nct_id>
  </id_info>
  <brief_title>Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ?</brief_title>
  <acronym>S3i</acronym>
  <official_title>Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Visceral hypersensitivity is frequent in IBS population up to 60% and is correlated with
      severity and altered quality of life. Sleeping troubles are most frequent in IBS population.
      Insomnia is a frequent disorder with an important cost for healthcare. Insomnia could
      decrease pain threshold.

      Visceral hypersensitivity was never measure in patients with insomnia. The hypothesis is IBS
      patients with insomnia probably have lower visceral pain threshold.

      The objective is to assess pain threshold during a barostat procedure in in IBS patients with
      or without insomnia in comparison with healthy volunteers or patients with insomnia.

      If the hypothesis are confirmed, insomnia should be look at in IBS patients and its
      treatments could improve visceral hypersensitivity and IBS symptoms.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pressure threshold measured during the barostat procedure</measure>
    <time_frame>Day 35</time_frame>
    <description>Pressure threshold measured during the barostat procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score at HAD anxiety and depression scale</measure>
    <time_frame>Day 35</time_frame>
    <description>Score at HAD anxiety and depression scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score at Pittsburg sleep quality index</measure>
    <time_frame>Day 35</time_frame>
    <description>Score at Pittsburg sleep quality index</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">77</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with insomnia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with irritable bowel syndrome</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with irritable bowel syndrome and insomnia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Barostat procedure</intervention_name>
    <description>Pressure threshold will be measured during the barostat procedure</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with insomnia</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome and insomnia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anxiety and Depression Evaluation</intervention_name>
    <description>Anxiety and Depression will be measured using HAD anxiety and depression scale</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with insomnia</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome and insomnia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Assessment of sleep quality</intervention_name>
    <description>Sleep quality will be measured using Pittsburg sleep quality index</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with insomnia</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome</arm_group_label>
    <arm_group_label>Patients with irritable bowel syndrome and insomnia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy volunteers

             - Person aged over 18 years with no IBS and no Insomnia

          2. Patients with insomnia

             - Patient aged over 18 years with no IBS and no Insomnia

          3. Patients with IBS

             - Patient aged over 18 years with IBS

          4. patients with insomnia and IBS - Patient aged over 18 years with IBS

        Exclusion Criteria:

          -  Active chronic organic disease

          -  Endometriosis

          -  Opioids consumption

          -  Change in chronic treatment in the last 30 days

          -  Hypersensitivity to Normacol

          -  Patient with blood dyscrasia disorder known or identified, anticoagulant or
             antiplatelet treatments

          -  Rectal pathology

          -  Intestinal occlusion

          -  Severe renal failure

          -  Sodium retention

          -  Anal pathology (anal fissure, hemorrhoidal thrombosis)

          -  Person with administrative or judicial decision or under legal protection measure

          -  Patient participating in another trial in the last 30 days

          -  Pregnant or breastfeeding women

          -  Impossibility to keep fasting for 12 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chloé MECHIOR, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chloé MECHIOR, MD</last_name>
    <phone>+3323288</phone>
    <phone_ext>8990</phone_ext>
    <email>chloe.melchior@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien BLOT</last_name>
    <phone>+3323288</phone>
    <phone_ext>8265</phone_ext>
    <email>julien.blot@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Chloé MELCHIOR, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marie NETCHITAILO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 15, 2019</study_first_submitted>
  <study_first_submitted_qc>November 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2019</study_first_posted>
  <last_update_submitted>June 26, 2020</last_update_submitted>
  <last_update_submitted_qc>June 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>visceral hypersensitivity</keyword>
  <keyword>Insomnia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

